Two stocks in Healthcare
Novo Nordisk A/S vs Ypsomed Holding: profit, growth, debt and price compared
Novo Nordisk A/S is stronger on 4 of 7 figures: profit margin, sales growth, price for its expected profit and dividend. Ypsomed Holding is stronger on 3: debt, analysts' view and price trend.
Save both stocks to your watchlist and revisit their latest fundamentals.
| Novo Nordisk A/SNOVO-B.CO | Ypsomed HoldingYPSN.SW | |
|---|---|---|
| Net margin | Stronger: 33.9% | 30.4% |
| Revenue growth, past year | Stronger: +5.60% | −13.30% |
| Debt to equity | 61.7% | Stronger: 34.9% |
| Forward P/E | Stronger: 12.0× | 28.8× |
| Dividend yield | Stronger: 4.25% | 1.04% |
| Analysts | Hold · 24 | Stronger: Buy · 14 |
| From its 200-day average | −7.0% | Stronger: +21.2% |
Share price over the past year
- Novo Nordisk A/S−13.2%
- Ypsomed Holding+34.1%
17 Nov 202518 Nov 2026
Novo Nordisk A/S or Ypsomed Holding: which is stronger?
- NOVO-B.CO
Which is more profitable?
Novo Nordisk A/S keeps more of each sale as profit: 33.9% against 30.4%.
- NOVO-B.CO
Which is growing its sales faster?
Novo Nordisk A/S is growing its sales faster: +5.60% over the past year, against −13.30%.
- YPSN.SW
Which has borrowed less?
Ypsomed Holding has borrowed less: its debt is 34.9% of what its shareholders own, against 61.7% for Novo Nordisk A/S.
- NOVO-B.CO
Which costs less for the profit it is expected to make?
Novo Nordisk A/S costs less for the profit it is expected to make: 12.0× its forward earnings, against 28.8×.
- NOVO-B.CO
Which pays more in dividends?
Novo Nordisk A/S pays more back in dividends for what a share costs: 4.25% a year, against 1.04%.
- YPSN.SW
Which do analysts rate higher?
Analysts are warmer on Ypsomed Holding: Buy, against Hold for Novo Nordisk A/S.
- YPSN.SW
Which is in the stronger price trend?
Ypsomed Holding's price is in the stronger trend: 21.2% above its 200-day average, against 7.0% below.
What each company does
NOVO-B.CONovo Nordisk A/S
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products.
Reports results on 3 February 2027
YPSN.SWYpsomed Holding
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally.
Reports results on 19 May 2027
This comparison is just the starting point.
Discover opportunities, understand companies and compare investments in one place. See how StratDeck works
Keep researching
Where next
More comparisons
Free email
Up to speed in minutes, four times a week
Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.
Early access
Become a StratDeck founding user
Use StratDeck, tell us what's missing, and help decide what we build next.
100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.